Drug Shortage Report for PRO-ATENOLOL
| Report ID | 265323 |
| Drug Identification Number | 00828807 |
| Brand name | ATENOLOL |
| Common or Proper name | ATENOLOL |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | ATENOLOL |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-10-06 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2025-09-12 |
| Shortage status | Avoided shortage |
| Updated date | 2025-09-12 |
| Company comments | Regulatory submission delays |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-09-12 | French | Compare |
| v5 | 2025-09-12 | English | Compare |
| v4 | 2025-08-29 | French | Compare |
| v3 | 2025-08-29 | English | Compare |
| v2 | 2025-08-15 | French | Compare |
| v1 | 2025-08-15 | English | Compare |
Showing 1 to 6 of 6